Recent research demonstrated that tumor-derived T-reg cells exhibit an accelerated glucose uptake, competing with effector T cells for glucose through TLR8 signaling, leading to MAPK activation, which induces T cell senescence (180). The gene discussed is TLR8; the disease is neoplasm.